Sarepta Therapeutics

Sarepta Therapeutics is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Sarepta Therapeutics products.

Drugs from Sarepta Therapeutics supported via NPP

BrandGenericCategoryIndication
Vyondys 53golodirsenNeuromuscular (DMD)DMD exon 53 skipping therapy

How NPP access to Sarepta Therapeutics products works

Reserve Meds sources Sarepta Therapeutics products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.

Not affiliated with Sarepta Therapeutics

Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Sarepta Therapeutics.

Start a request

Start a request for a Sarepta Therapeutics product

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI clinical and regulatory review agents. A US-licensed human pharmacist (sourced through Altima Care, a US-licensed specialty wholesaler) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: .
WhatsApp